[HTML][HTML] IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
RI Fernando, DH Hamilton, C Dominguez, JM David… - Oncotarget, 2016 - ncbi.nlm.nih.gov
A signaling pathway that is frequently deregulated in human carcinomas and has been
explored as a therapeutic target involves the activation of the epidermal growth factor …
explored as a therapeutic target involves the activation of the epidermal growth factor …
[PDF][PDF] IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
RI Fernando, DH Hamilton, C Dominguez, JM David… - pdfs.semanticscholar.org
ABSTRACT A signaling pathway that is frequently deregulated in human carcinomas and
has been explored as a therapeutic target involves the activation of the epidermal growth …
has been explored as a therapeutic target involves the activation of the epidermal growth …
[HTML][HTML] IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
RI Fernando, DH Hamilton, C Dominguez, JM David… - Oncotarget, 2016 - oncotarget.com
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib | Oncotarget Online
ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission Current Volume …
ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission Current Volume …
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
RI Fernando, DH Hamilton, C Dominguez… - …, 2016 - pubmed.ncbi.nlm.nih.gov
A signaling pathway that is frequently deregulated in human carcinomas and has been
explored as a therapeutic target involves the activation of the epidermal growth factor …
explored as a therapeutic target involves the activation of the epidermal growth factor …
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib.
RI Fernando, DH Hamilton, C Dominguez, JM David… - Oncotarget, 2016 - europepmc.org
A signaling pathway that is frequently deregulated in human carcinomas and has been
explored as a therapeutic target involves the activation of the epidermal growth factor …
explored as a therapeutic target involves the activation of the epidermal growth factor …
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
RI Fernando, DH Hamilton, C Dominguez, JM David… - Oncotarget, 2016 - oncotarget.com
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib | Oncotarget Online
ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission Current Volume …
ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission Current Volume …
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib.
RI Fernando, DH Hamilton, C Dominguez, JM David… - Oncotarget, 2016 - europepmc.org
A signaling pathway that is frequently deregulated in human carcinomas and has been
explored as a therapeutic target involves the activation of the epidermal growth factor …
explored as a therapeutic target involves the activation of the epidermal growth factor …